385 related articles for article (PubMed ID: 17973637)
1. Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron.
Dizdar V; Gilja OH; Hausken T
Neurogastroenterol Motil; 2007 Dec; 19(12):977-82. PubMed ID: 17973637
[TBL] [Abstract][Full Text] [Related]
2. Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters.
Haag S; Talley NJ; Holtmann G
Gut; 2004 Oct; 53(10):1445-51. PubMed ID: 15361493
[TBL] [Abstract][Full Text] [Related]
3. Effects of a 5-HT(3) antagonist, ondansetron, on fasting and postprandial small bowel water content assessed by magnetic resonance imaging.
Marciani L; Wright J; Foley S; Hoad CL; Totman JJ; Bush D; Hartley C; Armstrong A; Manby P; Blackshaw E; Perkins AC; Gowland PA; Spiller RC
Aliment Pharmacol Ther; 2010 Sep; 32(5):655-63. PubMed ID: 20626735
[TBL] [Abstract][Full Text] [Related]
4. Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia.
Dizdar V; Spiller R; Singh G; Hanevik K; Gilja OH; El-Salhy M; Hausken T
Aliment Pharmacol Ther; 2010 Apr; 31(8):883-91. PubMed ID: 20132151
[TBL] [Abstract][Full Text] [Related]
5. A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea.
Lee KJ; Demarchi B; Demedts I; Sifrim D; Raeymaekers P; Tack J
Am J Gastroenterol; 2004 Sep; 99(9):1765-73. PubMed ID: 15330916
[TBL] [Abstract][Full Text] [Related]
6. Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome.
Stanghellini V; Tosetti C; Barbara G; De Giorgio R; Cogliandro L; Cogliandro R; Corinaldesi R
Am J Gastroenterol; 2002 Nov; 97(11):2738-43. PubMed ID: 12425541
[TBL] [Abstract][Full Text] [Related]
7. Lactulose breath test results in patients with persistent abdominal symptoms following Giardia lamblia infection.
Morken MH; Nysaeter G; Strand EA; Hausken T; Berstad A
Scand J Gastroenterol; 2008; 43(2):141-5. PubMed ID: 17943632
[TBL] [Abstract][Full Text] [Related]
8. Subjective health complaints and quality of life in patients with irritable bowel syndrome following Giardia lamblia infection: a case control study.
Morken MH; Lind RA; Valeur J; Wilhelmsen I; Berstad A
Scand J Gastroenterol; 2009; 44(3):308-13. PubMed ID: 19031266
[TBL] [Abstract][Full Text] [Related]
9. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia.
Corsetti M; Caenepeel P; Fischler B; Janssens J; Tack J
Am J Gastroenterol; 2004 Jun; 99(6):1152-9. PubMed ID: 15180740
[TBL] [Abstract][Full Text] [Related]
10. Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?
Maxton DG; Morris J; Whorwell PJ
Aliment Pharmacol Ther; 1996 Aug; 10(4):595-9. PubMed ID: 8853764
[TBL] [Abstract][Full Text] [Related]
11. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia.
Tack J; Masclee A; Heading R; Berstad A; Piessevaux H; Popiela T; Vandenberghe A; Kato H
Neurogastroenterol Motil; 2009 Mar; 21(3):272-80. PubMed ID: 19254354
[TBL] [Abstract][Full Text] [Related]
12. The 5-HT4 antagonist R216073 does not affect gastric motor and sensory function in patients with functional dyspepsia.
Van Lelyveld N; Ter Linde J; Baron A; Mundt M; Wajs E; Samsom M
Aliment Pharmacol Ther; 2006 Aug; 24(4):669-77. PubMed ID: 16827813
[TBL] [Abstract][Full Text] [Related]
13. A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia.
Tack J; Van Den Elzen B; Tytgat G; Wajs E; Van Nueten L; De Ridder F; Boeckxstaens G
Neurogastroenterol Motil; 2009 Jun; 21(6):619-26, e23-4. PubMed ID: 19220756
[TBL] [Abstract][Full Text] [Related]
14. Relationship between symptom pattern, assessed by the PAGI-SYM questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia.
Kindt S; Dubois D; Van Oudenhove L; Caenepeel P; Arts J; Bisschops R; Tack J
Neurogastroenterol Motil; 2009 Nov; 21(11):1183-e105. PubMed ID: 19663903
[TBL] [Abstract][Full Text] [Related]
15. Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study.
Braak B; Klooker TK; Wouters MM; Lei A; van den Wijngaard RM; Boeckxstaens GE
Aliment Pharmacol Ther; 2011 Sep; 34(6):638-48. PubMed ID: 21767283
[TBL] [Abstract][Full Text] [Related]
16. Unsuppressed postprandial phasic contractility in the proximal stomach in functional dyspepsia: relevance to symptoms.
Simrén M; Vos R; Janssens J; Tack J
Am J Gastroenterol; 2003 Oct; 98(10):2169-75. PubMed ID: 14572563
[TBL] [Abstract][Full Text] [Related]
17. Effect of the 5-HT3 receptor antagonist, ondansetron, on gastric size in dyspeptic patients with impaired gastric accommodation.
Marzio L; Cappello G; Grossi L; Manzoli L
Dig Liver Dis; 2008 Mar; 40(3):188-93. PubMed ID: 18242155
[TBL] [Abstract][Full Text] [Related]
18. Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity.
Gonlachanvit S; Mahayosnond A; Kullavanijaya P
Neurogastroenterol Motil; 2009 Jan; 21(1):23-32. PubMed ID: 18647268
[TBL] [Abstract][Full Text] [Related]
19. Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study.
Cremonini F; Camilleri M; McKinzie S; Carlson P; Camilleri CE; Burton D; Thomforde G; Urrutia R; Zinsmeister AR
Am J Gastroenterol; 2005 Mar; 100(3):652-63. PubMed ID: 15743365
[TBL] [Abstract][Full Text] [Related]
20. Decreased Basal and postprandial plasma serotonin levels in patients with functional dyspepsia.
Cheung CK; Lee YY; Chan Y; Cheong PK; Law WT; Lee SF; Sung JJ; Chan FK; Wu JC
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1125-9. PubMed ID: 23591288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
